Barbara Klencke

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Pasadena, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Zoran Zdraveski, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Barbara Klencke

Form 4 holding Director

TScan Therapeutics, Inc.

Security class
Voting Common Stock
Shares / value
45,000
Estimated value
$238,050
Report date
23 Sep 2024
Price
$5.29
Ownership
Direct
Form 4 holding Director

Xencor Inc

Security class
Common Stock
Shares / value
19,672
Estimated value
$206,752
Report date
12 Jun 2025
Price
$10.51
Ownership
Direct
Form 4 holding Director

TScan Therapeutics, Inc.

Security class
Voting Common Stock
Shares / value
25,000
Estimated value
$132,250
Report date
23 Sep 2024
Price
$5.29
Ownership
By Trust
Form 4 holding Chief Medical Officer

ALX ONCOLOGY HOLDINGS INC

Security class
Stock option (right to buy)
Shares / value
100,000
Estimated value
Report date
16 Apr 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Xencor Inc

Security class
Stock Option (Right to Buy)
Shares / value
27,372
Estimated value
Report date
12 Jun 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

eFFECTOR Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
800
Estimated value
Report date
13 Jun 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Medical Officer

Sierra Oncology, Inc.

Security class
Common Stock
Shares / value
0
Estimated value
Report date
01 Jul 2022
Price
$55.00
Ownership
By spouse
Form 4 holding Chief Medical Officer

Sierra Oncology, Inc.

Security class
Common Stock
Shares / value
0
Estimated value
Report date
01 Jul 2022
Price
$55.00
Ownership
Direct
Form 4 holding Chief Medical Officer

Sierra Oncology, Inc.

Security class
Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
01 Jul 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Barbara Klencke

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .